Roche will use Dyno’s technology, through which Dyno applies AI and high-throughput in vivo data collection to engineering AAV capsids.

The Medical Advertising Hall of Fame (MAHF) announced its 2025 inductees Thursday morning. The organization is inducting ...

Genus Fly ’Keeper Gael. Twenty summers ago, the roaming Rossie ventured far from goal to score 1-1 (from a penalty and ...

Win Some Lose Some lived up to his name by following up a loss with a victory for the third time in a row when he pounced ...

A tidy gamble was landed in the Crottys Lake Maiden Hurdle, in which Marlpark made all the running to land the spoils for John Ryan and jockey Shane Fitzgerald ...

George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

Existing gene therapies have primarily used a small number of naturally occurring AAV vectors limited by low delivery efficiency as well as problems with pre-existing immunity and manufacturability.

Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery.The ...

NFL News: Andy Reid's Chiefs sign a key veteran to help Patrick Mahomes, Travis Kelce The Ocean Has Massive Energy Reserves.